Text Messaging (TM) + No Patient Navigation for COVID-19
N/A
Waitlist Available
Led By Guilherme Del Fiol, MD PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Speak English or Spanish
Current patient of a participating community health center
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upyear 1
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will use tech interventions to increase COVID-19 testing and vaccination uptake among underserved populations in Utah.
Eligible Conditions
- COVID-19
- Coronavirus
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ year 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~year 1
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Testing
Secondary outcome measures
Reach- Accept Vaccine
Reach-Accept Testing
Reach-Engage Testing
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Text Messaging (TM) + No Patient NavigationActive Control1 Intervention
Bidirectional text messaging with a one-touch response to connect patients to vaccination or mailed at-home rapid test kits for use as needed.
Patients will not receive patient navigation.
Group II: Text Message (TM) + Request (RPN)Active Control2 Interventions
Bidirectional text messaging with a one-touch response to connect patients to vaccination or mailed at-home rapid test kits for use as needed.
RPN will provide patients the opportunity to reply PERSON (for connection to a PN) in response to a TM offering connection to testing and/or vaccination.
Find a site
Who is running the clinical trial?
University of UtahLead Sponsor
1,049 Previous Clinical Trials
1,662,695 Total Patients Enrolled
14 Trials studying COVID-19
438,590 Patients Enrolled for COVID-19
Association for Utah Community HealthOTHER
3 Previous Clinical Trials
262,395 Total Patients Enrolled
3 Trials studying COVID-19
262,395 Patients Enrolled for COVID-19
National Institutes of Health (NIH)NIH
2,611 Previous Clinical Trials
6,621,269 Total Patients Enrolled
31 Trials studying COVID-19
292,139 Patients Enrolled for COVID-19
National Institute on Minority Health and Health Disparities (NIMHD)NIH
338 Previous Clinical Trials
1,147,028 Total Patients Enrolled
14 Trials studying COVID-19
112,715 Patients Enrolled for COVID-19
Utah Department of HealthOTHER
6 Previous Clinical Trials
438,052 Total Patients Enrolled
4 Trials studying COVID-19
263,945 Patients Enrolled for COVID-19
Guilherme Del Fiol, MD PhDPrincipal Investigator
University of Utah1 Previous Clinical Trials
42,069 Total Patients Enrolled
1 Trials studying COVID-19
42,069 Patients Enrolled for COVID-19
Media Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any participants needed for this investigation?
"Affirmative, the clinical trial is actively recruiting according to data available on clinicaltrials.gov. The study was first published on December 15th 2022 and edited most recently on May 8th 2023. It requires 112479 individuals from a single site for participation."
Answered by AI
How many participants are being monitored in this clinical investigation?
"Affirmative, the information on clinicaltrials.gov asserts that this medical trial is actively enlisting participants. This study was initially announced on December 15th 2022 and edited most recently on May 8th 2023, with a requirement for 112479 patients to be recruited from 1 site."
Answered by AI
Recent research and studies